Light-activated dyes show promise in targeting cancer cells
Melanoma is one of the most aggressive skin cancers, with more than 300,000 new cases reported worldwide each year. In Europe, the number of diagnoses has been rising rapidly.
Radiation plus combination immunotherapy may help preserve bladder in some patients with cancer
Patients with localized muscle-invasive bladder cancer (MIBC) who received radiation plus the immune checkpoint inhibitors (ICIs) durvalumab (Imfinzi) and tremelimumab (Imjudo) had durable responses that allowed for bladder preservation, according to results from the IMMUNOPRESERVE clinical trial
Scientists discover the ‘roadmap’ that aggressive cancer uses to spread
New research published in Nature Communications reveals how cancer cells are altered by their surroundings, enabling them to change their shape and break out of a tumor.
Urinary DNA methylation test shows some promise for noninvasive bladder cancer screening
Researchers led by the University of Ulsan College of Medicine, Korea, have checked the performance of a noninvasive urinary DNA methylation test for bladder cancer diagnosis.
Researchers discover why some colon cancers resist treatment
Researchers at The Tisch Cancer Institute at Mount Sinai have uncovered a major reason why some colorectal cancers (CRC) resist treatment.
Scientists propose CDK2 enzyme as new target for cancer therapy
An enzyme called cyclin-dependent kinase 2 (CDK2) regulates the cell cycle and may have the potential to drive therapeutic resistance to common breast cancer drugs—including a class of targeted treatments known as CDK4/6 inhibitors.
Ultrasound imaging of breast cancer tumors offers noninvasive monitoring of treatment effectiveness
In the ongoing battle against triple negative breast cancer, Vanderbilt researchers have uncovered a promising non-invasive method to track how tumors respond to radiation and immunotherapy, which uses the body’s own immune system to fight cancer.
A newly discovered biomarker can predict cancer aggressiveness
Using a new technology and computational method, researchers from Fred Hutch Cancer Center and The University of Texas MD Anderson Cancer Center have uncovered a biomarker capable of accurately predicting outcomes in meningioma brain tumors and breast cancers.
Immunotherapy reduces sunspots by 65% in cancer patients
University of Queensland researchers have discovered immunotherapy, when used to treat people with advanced cancers, also helps reduce sunspots and skin cancers by at least 65%.
Innovative molecular therapies target and disrupt uncontrollable growth of cancer cells
wo new studies represent a big step toward developing innovative molecular therapies capable of disrupting the uncontrollable growth of cancers at their roots.
Breast cancer treatment advances with light-activated ‘smart bomb’
Scientists have developed new light-sensitive chemicals that can radically improve the treatment of aggressive cancers with minimal side effects. In mouse tests, the new therapy completely eradicated metastatic breast cancer tumors.
Short-course radiation matches standard therapy for endometrial cancer
In a randomized clinical trial, researchers from Huntsman Cancer Institute at the University of Utah (the U) have found that short-course, higher-dose vaginal brachytherapy for endometrial cancer had similar effectiveness to more frequent, lower dose sessions.
